Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016 Post author:Sam Post published:January 31, 2018 Post category:BioPharma Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace You Might Also Like Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data May 30, 2017 IMRALDI, Biogen???s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union August 24, 2017 Mirati Therapeutics To Participate In Immuno-Oncology Panel Discussion At The 2017 Conference August 30, 2017
IMRALDI, Biogen???s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union August 24, 2017
Mirati Therapeutics To Participate In Immuno-Oncology Panel Discussion At The 2017 Conference August 30, 2017